Reports related to this article:
Project(s): View 4 related projects in PECWeb
Plant(s): View 3 related plants in PECWeb
Released June 03, 2014 | SUGAR LAND
en
Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The U.S. Midwest region is not often found on "top" lists for the Life Science sector. Despite this, the region as a whole is set to begin construction on more than $1.75 billion in capital construction projects before the year ends. To be sure, the bulk of the projects are institutional or publically sourced, but being able to offer intellectual capital and top-flight facilities has proved a powerful draw in other locations for the commercial sector of the business.
Click on the image at right for a chart detailing 2014 Midwest Pharma-Biotech Projects by state.
So far, the region, which includes the states of Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota and South Dakota, has 73 reported projects with a total investment value (TIV) of $1.77 billion that are scheduled for kick-off in 2014. This translates to a $24 million-per-project average investment.
Click here to gain instant access to the all-new 2014 North American Pharmaceutical-Biotech Outlook.
The federal government plans to invest $714 million in the National Bio and Agro-Defense Facility (NBAF). While funding for the nearly 600,000-square-foot research facility, slated for Manhattan, Kansas, is still subject to debate in Washington, the most recent news has it set to launch construction this year. The national lab will replace the aging Plum Island Animal Disease Center (PIADC) in New York. Filled with elaborate laboratories ranging in biosafety levels (BSL) 1 through 4 (with the BSL-4 labs researching the most lethal of diseases and germs), the focus of study will center on integrated human, foreign animal and zoonotic diseases, as well as the development of large livestock vaccines. The project team includes designers Perkins + Will (Atlanta, Georgia) and a joint venture by McCarthy and Mortenson (McMjv) as construction managers.
When the huge financial plum of the NBAF is removed from the equation, the region can still boast a number of high-dollar projects. The University of North Dakota is spending $124 million to build a new School of Medicine complex in Grand Forks. The project team includes Perkins + Will (Minneapolis, Minnesota, JLG Architects (Grand Forks, North Dakota), Community Contractors (Grand Fork, North Dakota) and PCL Construction (Burnsville, Minnesota). Construction on the 376,000-square-foot complex should start this month and be complete in two years.
A little further south, the University of Minnesota-Twin Cities campus will build the $63 million Microbiology Research Laboratory. BWBR Architects (Saint Paul, Minnesota) designed the four-story, 80,000-square-foot building to accommodate research focused on deadly illnesses such as HIV/AIDS/TB and fungal diseases. Another field of investigation will be into microbiological problems, such as antibiotic-resistant bacteria and viruses that cause cold sores and life-threatening infections in transplant recipients. Mortenson is scheduled to complete construction of the project in the fall of 2015. The project is part of the university's ambitious $420 million investment for its advanced research Biomedical Discovery District (BDD).
Baxter Healthcare (Deerfield, Illinois) purchased the former Genmab manufacturing plant in Brooklyn Park, Minnesota. The company is investing $60 million in a series of projects to upgrade and convert the 215,000-square-foot facility, which already houses 119,000 square feet of biologics manufacturing. Possible future uses may include biosimilar production. Project team members include CBR USA (Kansas City, Missouri) and McGough Construction (Saint Paul, Minnesota).
View Plant Profile - 157240 1059206 1064916 1069966
View Project Report - 300127381 300102972 300115187 033001345
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities.
Click on the image at right for a chart detailing 2014 Midwest Pharma-Biotech Projects by state.So far, the region, which includes the states of Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota and South Dakota, has 73 reported projects with a total investment value (TIV) of $1.77 billion that are scheduled for kick-off in 2014. This translates to a $24 million-per-project average investment.
Click here to gain instant access to the all-new 2014 North American Pharmaceutical-Biotech Outlook.
The federal government plans to invest $714 million in the National Bio and Agro-Defense Facility (NBAF). While funding for the nearly 600,000-square-foot research facility, slated for Manhattan, Kansas, is still subject to debate in Washington, the most recent news has it set to launch construction this year. The national lab will replace the aging Plum Island Animal Disease Center (PIADC) in New York. Filled with elaborate laboratories ranging in biosafety levels (BSL) 1 through 4 (with the BSL-4 labs researching the most lethal of diseases and germs), the focus of study will center on integrated human, foreign animal and zoonotic diseases, as well as the development of large livestock vaccines. The project team includes designers Perkins + Will (Atlanta, Georgia) and a joint venture by McCarthy and Mortenson (McMjv) as construction managers.
When the huge financial plum of the NBAF is removed from the equation, the region can still boast a number of high-dollar projects. The University of North Dakota is spending $124 million to build a new School of Medicine complex in Grand Forks. The project team includes Perkins + Will (Minneapolis, Minnesota, JLG Architects (Grand Forks, North Dakota), Community Contractors (Grand Fork, North Dakota) and PCL Construction (Burnsville, Minnesota). Construction on the 376,000-square-foot complex should start this month and be complete in two years.
A little further south, the University of Minnesota-Twin Cities campus will build the $63 million Microbiology Research Laboratory. BWBR Architects (Saint Paul, Minnesota) designed the four-story, 80,000-square-foot building to accommodate research focused on deadly illnesses such as HIV/AIDS/TB and fungal diseases. Another field of investigation will be into microbiological problems, such as antibiotic-resistant bacteria and viruses that cause cold sores and life-threatening infections in transplant recipients. Mortenson is scheduled to complete construction of the project in the fall of 2015. The project is part of the university's ambitious $420 million investment for its advanced research Biomedical Discovery District (BDD).
Baxter Healthcare (Deerfield, Illinois) purchased the former Genmab manufacturing plant in Brooklyn Park, Minnesota. The company is investing $60 million in a series of projects to upgrade and convert the 215,000-square-foot facility, which already houses 119,000 square feet of biologics manufacturing. Possible future uses may include biosimilar production. Project team members include CBR USA (Kansas City, Missouri) and McGough Construction (Saint Paul, Minnesota).
View Plant Profile - 157240 1059206 1064916 1069966
View Project Report - 300127381 300102972 300115187 033001345
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities.
